search
Back to results

Family Involvement in CBGT of OCD: a Randomized Controlled Trial

Primary Purpose

Obsessive-Compulsive Disorder

Status
Recruiting
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
FB-CBGT
CBGT
Sponsored by
University Hospital, Ghent
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obsessive-Compulsive Disorder focused on measuring Family based intervention, Cognitive behavioral group therapy, Exposure and response prevention, Family accommodation

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • the OCD patient with a score of at least 16 on Y-BOCS
  • patient and family member fluent in Dutch
  • patient and family member both willing to attend all treatment sessions together.

Exclusion Criteria:

  • current severe suicidality
  • current substance abuse
  • psychotic symptoms and
  • OCD treated with deep brain stimulation

Sites / Locations

  • Ghent University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Family-based cognitive behavioral group therapy (FB-CBGT)

Cognitive-behavioral group therapy (CBGT) without family

Arm Description

One family member of each patient will be involved during all 12 CBGT sessions. The CBGT program that will be employed in the present study is a protocoled therapy consisting of psychoeducation, ERP techniques, cognitive tools to change dysfunctional thoughts and beliefs, strategies to prevent relapses, discussion on the family involvement (e.g. FA, burden, …) and homework exercises after each session.

Each patient will be involved during all 12 CBGT sessions. The CBGT program that will be employed in the present study is a protocoled therapy consisting of psychoeducation, ERP techniques, cognitive tools to change dysfunctional thoughts and beliefs, strategies to prevent relapses, discussion on the family involvement (e.g. FA, burden, …) and homework exercises after each session., without the involvement of family members.

Outcomes

Primary Outcome Measures

Faster decrease and longer lasting improvement (less relapse) of OCD symptoms in patients
Improvement of OCD symptoms will be measured by the Y-BOCS
Faster decrease and longer lasting improvement of family accommodation in family members
Improvement of family accommodation will be measured by the family accommodation scale (FAS)

Secondary Outcome Measures

A reduction in anxiety and depression in patients and family members
The Hospital Anxiety and Depressive Scale (HADS) will be used to measure the presence of depression and anxiety and changes in depression and anxiety rates
Increase of quality of life (QOL) in patients
The Quality of Life Questionnaire (WHOQOL-BREF) will be administered to assess the perceived quality of life and emotional well-being in patients
An improvement in family functioning measured by the SCORE-15 in patients and family members
The Systemic Clinical Outcome and Routine Evaluation 15-item version (SCORE-15) will be administered to assess the outcome in systemic family therapy and other family-oriented services
An improvement in family functioning measured by the BPNSFS in patients and family members
The Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS) -addresses both need satisfaction and frustration in relationships. Whereas need satisfaction is associated with well-being, need frustration is associated with ill-being. Self-determination theory posits three universal psychological needs: autonomy; competence; and relatedness, and suggests that these must be present satisfactorily for people to maintain optimal performance and well-being.
An improvement in family functioning measured by the perceived criticism measure (PCM) in patients and family members
The perceived criticism measure (PCM) consists of a 10-point Likert-type scale to describe a relative's degree of criticism of him of her. The patients' perception on their relatives' behavior may be the proximal factor in expressed emotions relationship to treatment response and relapse. This measure proved to be a strong predictor of outcome for outpatients with OCD.
A decrease of burden in family members
Family burden will be evaluated with the Zarit Burden Interview (ZBI) 22-item version, a self-report measure. The ZBI assesses the perceived burden in the caregivers of patients with psychiatric disorders.
Evaluation therapeutic sessions
In order to assess how patients and family members evaluate the therapeutic relation, goals and topics, approach during the therapeutic session the Session Rating Scale (SRS V.3.0) will be administered.

Full Information

First Posted
August 2, 2019
Last Updated
December 8, 2022
Sponsor
University Hospital, Ghent
search

1. Study Identification

Unique Protocol Identification Number
NCT04071990
Brief Title
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
Official Title
Impact of Involvement of the Family in the Cognitive Behavioral Group Therapy for Obsessive-Compulsive Disorder: a Randomized Controlled Trial.
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 3, 2019 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Ghent

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
With a lifetime prevalence of 1-3% Obsessive-Compulsive Disorder (OCD) is a chronic and disabling psychiatric disorder with considerable burden for the individual and society. Cognitive-behavioural group therapy (CBGT) is effective in reducing the intensity of OCD symptoms and it improves the OCD patient's quality of life. There is also growing evidence that family accommodation (FA) maintains and/or facilitates OCD symptoms, reinforces fear and avoidance behaviours in patients with OCD and is associated with family burden. Considering the promising results of involvement of family in CBGT on OCD symptoms and FA, the current study aims at investigating the effects of the involvement of the family in a 12-week CBGT protocol on the OCD symptoms, FA, burden, QOL, anxiety and depressive symptoms in OCD patients and their live-in relatives. Eighty patients with OCD and their live-in family members (partner, parent, sibling, …) between 18-65 years old will be included in this randomized controlled trial. Patients and family members will be randomly assigned to CBGT with the involvement of family or to CBGT without involvement of family. The primary goal of this study is to evaluate the effects of the involvement of live-in family members during a 12-week CBGT on OCD symptomatology and family accommodation during a 12-month follow-up period. In a secondary stage, we will explore whether the involvement of live-in family members during a 12-week CBGT will ameliorate anxiety and depressive symptoms, QOL, family functioning and burden in the patients and their live-in family.
Detailed Description
Participants will be recruited at the Centre for OCD at the Ghent University Hospital (UZ Gent) located in Belgium. A group of 80 patients and 80 live-in family members (partner, parent, sibling), between 18 and 65 years old. The patients with OCD will be selected based on the Diagnostic and Statistical Manual (DSM-5) diagnostic criteria for obsessive-compulsive disorder using the semi-structured Mini International Neuropsychiatric Interview (MINI screening version 7.0.2)(60). Other inclusion criteria are (a) the OCD patient with a score of at least 16 on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), (b) patient and family member fluent in Dutch and (c) both willing to attend all treatment sessions together. To maximize the generalizability of our sample, we did not exclude patients if they had comorbid mood or anxiety disorders, as long as OCD was the principal diagnosis. Patients and family members will be recruited before randomization, because the aim of this study is to investigate the impact of the involvement of the family in the CBGT. At the start of the experiment we will ask patients and their family members to sign the informed consent. Randomization occurs after oral and written informed consent and patients and family members will be notified about the treatment condition after randomization. After randomization the patient and family member will be allocated to one of the two treatment arms: (a) CBGT with involvement of family of family-based CBGT (FB-CBGT) (intervention) or (b) CBGT without involvement of family (control). The CBGT program exists of a fixed 12-week protocol, involving psycho-education, exposure and response prevention (ERP), cognitive restructuring, and the discussion about the family system.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obsessive-Compulsive Disorder
Keywords
Family based intervention, Cognitive behavioral group therapy, Exposure and response prevention, Family accommodation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
After randomization the patient an family member will be allocated to one of the two groups: (a) CBGT with involvement of family (intervention) or (b) CBGT without involvement of family (control), both groups will exist of 12 sessions
Masking
Care ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Family-based cognitive behavioral group therapy (FB-CBGT)
Arm Type
Active Comparator
Arm Description
One family member of each patient will be involved during all 12 CBGT sessions. The CBGT program that will be employed in the present study is a protocoled therapy consisting of psychoeducation, ERP techniques, cognitive tools to change dysfunctional thoughts and beliefs, strategies to prevent relapses, discussion on the family involvement (e.g. FA, burden, …) and homework exercises after each session.
Arm Title
Cognitive-behavioral group therapy (CBGT) without family
Arm Type
Placebo Comparator
Arm Description
Each patient will be involved during all 12 CBGT sessions. The CBGT program that will be employed in the present study is a protocoled therapy consisting of psychoeducation, ERP techniques, cognitive tools to change dysfunctional thoughts and beliefs, strategies to prevent relapses, discussion on the family involvement (e.g. FA, burden, …) and homework exercises after each session., without the involvement of family members.
Intervention Type
Behavioral
Intervention Name(s)
FB-CBGT
Intervention Description
CBGT for OCD patients, with Involvement of family members (partner, parent, sibling, ...)
Intervention Type
Behavioral
Intervention Name(s)
CBGT
Intervention Description
CBGT for OCD patients, without involvement of family members
Primary Outcome Measure Information:
Title
Faster decrease and longer lasting improvement (less relapse) of OCD symptoms in patients
Description
Improvement of OCD symptoms will be measured by the Y-BOCS
Time Frame
Y-BOCS will be completed at four time-points: at inclusion, after completion of the CBGT (an average of 3 months post baseline) and at 6 and 12 months post CBGT
Title
Faster decrease and longer lasting improvement of family accommodation in family members
Description
Improvement of family accommodation will be measured by the family accommodation scale (FAS)
Time Frame
The Family Accommodation Scale (FAS) will be completed at four time-points: at inclusion, after completion of the CBGT (an average of 3 months post baseline) and at 6 and 12 months post CBGT
Secondary Outcome Measure Information:
Title
A reduction in anxiety and depression in patients and family members
Description
The Hospital Anxiety and Depressive Scale (HADS) will be used to measure the presence of depression and anxiety and changes in depression and anxiety rates
Time Frame
The HADS will be completed at four time-points: at inclusion, after completion of the CBGT (an average of 3 months post baseline) and at 6 and 12 months post CBGT
Title
Increase of quality of life (QOL) in patients
Description
The Quality of Life Questionnaire (WHOQOL-BREF) will be administered to assess the perceived quality of life and emotional well-being in patients
Time Frame
The WHOQOL-BREF will be completed at four time-points: at inclusion, after completion of the CBGT (an average of 3 months post baseline) and at 6 and 12 months post CBGT
Title
An improvement in family functioning measured by the SCORE-15 in patients and family members
Description
The Systemic Clinical Outcome and Routine Evaluation 15-item version (SCORE-15) will be administered to assess the outcome in systemic family therapy and other family-oriented services
Time Frame
The SCORE-15 will be completed at four time-points: at inclusion, after completion of the CBGT(an average of 3 months post baseline) and at 6 and 12 months post CBGT
Title
An improvement in family functioning measured by the BPNSFS in patients and family members
Description
The Basic Psychological Need Satisfaction and Frustration Scale (BPNSFS) -addresses both need satisfaction and frustration in relationships. Whereas need satisfaction is associated with well-being, need frustration is associated with ill-being. Self-determination theory posits three universal psychological needs: autonomy; competence; and relatedness, and suggests that these must be present satisfactorily for people to maintain optimal performance and well-being.
Time Frame
The BPNSFS will be completed at four time-points: at inclusion, after completion of the CBGT (an average of 3 months post baseline) and at 6 and 12 months post CBGT
Title
An improvement in family functioning measured by the perceived criticism measure (PCM) in patients and family members
Description
The perceived criticism measure (PCM) consists of a 10-point Likert-type scale to describe a relative's degree of criticism of him of her. The patients' perception on their relatives' behavior may be the proximal factor in expressed emotions relationship to treatment response and relapse. This measure proved to be a strong predictor of outcome for outpatients with OCD.
Time Frame
The PCM will be completed at four time-points: at inclusion, after completion of the CBGT (an average of 3 months post baseline) and at 6 and 12 months post CBGT
Title
A decrease of burden in family members
Description
Family burden will be evaluated with the Zarit Burden Interview (ZBI) 22-item version, a self-report measure. The ZBI assesses the perceived burden in the caregivers of patients with psychiatric disorders.
Time Frame
The ZBI will be completed at four time-points: at inclusion, after completion of the CBGT (an average of 3 months post baseline) and at 6 and 12 months post CBGT
Title
Evaluation therapeutic sessions
Description
In order to assess how patients and family members evaluate the therapeutic relation, goals and topics, approach during the therapeutic session the Session Rating Scale (SRS V.3.0) will be administered.
Time Frame
The SRS will be completed at 12 time-points: after all therapeutic sessions, 12 sessions in total, during 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: the OCD patient with a score of at least 16 on Y-BOCS patient and family member fluent in Dutch patient and family member both willing to attend all treatment sessions together. Exclusion Criteria: current severe suicidality current substance abuse psychotic symptoms and OCD treated with deep brain stimulation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Hannelore LN Tandt, MD
Phone
+3293324394
Email
hannelore.tandt@uzgent.be
First Name & Middle Initial & Last Name or Official Title & Degree
Gilbert MD Lemmens, MD, PhD
Phone
+3293324394
Email
gilbert.lemmens@uzgent.be
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gilbert MD Lemmens, MD, PhD
Organizational Affiliation
Ghent University Hospital, University Ghent
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kurt Audenaert, MD, PhD
Organizational Affiliation
Ghent University Hospital, University Ghent
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ghent University Hospital
City
Ghent
ZIP/Postal Code
9000
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Hannelore LN Tandt, MD
Phone
+3293324394
Email
hannelore.tandt@uzgent.be
First Name & Middle Initial & Last Name & Degree
Gilbert MD Lemmens, MD, PhD
Phone
+3293324394
Email
gilbert.lemmens@ugent.be

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
The datasets generated and/or analyzed during the current study are not publicly available due to confidentiality issues but are available from the corresponding author upon reasonable request.

Learn more about this trial

Family Involvement in CBGT of OCD: a Randomized Controlled Trial

We'll reach out to this number within 24 hrs